4.5 Review

Therapeutic Efficacy of Nasal Corticosteroids in COVID-19-Related Olfactory Dysfunction: A Comprehensive Systematic Review and Meta-analysis

Related references

Note: Only part of the references are listed.
Article Health Care Sciences & Services

Detecting the skewness of data from the five-number summary and its application in meta-analysis

Jiandong Shi et al.

Summary: For clinical studies with potentially skewed data, reporting the five-number summary instead of the sample mean and standard deviation is often suggested. However, transforming the five-number summary back to the mean and standard deviation may lead to unreliable conclusions in meta-analysis. In this article, a novel method for detecting data skewness using only the five-number summary and sample size is introduced, along with a new flow chart for handling skewed studies. Simulation results and real data examples demonstrate the effectiveness of this new method in meta-analysis and evidence-based medicine.

STATISTICAL METHODS IN MEDICAL RESEARCH (2023)

Article Otorhinolaryngology

Corticosteroid nasal irrigation as early treatment of olfactory dysfunction in COVID-19: A prospective randomised controlled trial

Jidapa Tragoonrungsea et al.

Summary: This study evaluated the efficacy of corticosteroid irrigation compared to saline or no nasal irrigation in restoring the sense of smell in COVID-19 patients with olfactory loss. The results showed that corticosteroid nasal irrigation was not superior to saline or no irrigation in terms of smell recovery.

CLINICAL OTOLARYNGOLOGY (2023)

Review Otorhinolaryngology

Efficacy of topical steroids for the treatment of olfactory disorders caused by COVID-19: A systematic review and meta-analysis

Do Hyun Kim et al.

Summary: This study assessed the effect of topical steroids on acute-onset olfactory dysfunction in patients infected with COVID-19. The findings showed that topical steroids improved olfactory function, but had no impact on the rate of full olfactory recovery.

CLINICAL OTOLARYNGOLOGY (2022)

Article Medicine, Research & Experimental

Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19

Masoumeh Hosseinpoor et al.

Summary: This study found that mometasone furoate nasal spray has a positive effect on improving smell dysfunction in post-COVID-19 patients. Although there was no significant difference in olfactory dysfunction between the two groups during the follow-up period, there was a significant improvement in olfactory scores in the mometasone group compared to the placebo group.

LARYNGOSCOPE (2022)

Review Immunology

Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis

Cong-wen Yang et al.

Summary: This study aimed to evaluate the effectiveness of umbilical cord mesenchymal stromal cells (UC-MSCs) in patients with COVID-19. The meta-analysis results showed that UC-MSCs can reduce mortality in COVID-19 patients and there is no significant correlation between adverse events and UC-MSC treatment. Additionally, treatment with UC-MSCs was found to suppress inflammation and improve pulmonary symptoms. Therefore, UC-MSCs hold promise as a safe and effective treatment for COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial

Emma J. A. Schepens et al.

Summary: This study shows that prednisolone does not improve olfactory function after COVID-19. Therefore, we recommend not prescribing prednisolone for patients with persistent olfactory disorders after COVID-19.

BMC MEDICINE (2022)

Article Surgery

Comparison of the Healing Effect of Nasal Saline Irrigation with Triamcinolone Acetonide Versus Nasal Saline Irrigation alone in COVID-19 Related Olfactory Dysfunction: A Randomized Controlled Study

Erkan Yildiz et al.

Summary: The study indicates that saline irrigation and nasal corticosteroid treatments are effective in treating olfactory dysfunction caused by COVID-19, with low side effects.

INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY (2022)

Article Otorhinolaryngology

Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines

Claire Hopkins et al.

Summary: This study aims to provide recommendations for the investigation and management of patients with new onset loss of sense of smell during the COVID-19 pandemic. A panel of 15 experts used the RAND/UCLA methodology to reach consensus on treatment options, referral guidelines, and imaging. Consensus was achieved on most statements after 2 rounds of ranking, with olfactory training recommended for all patients with persistent loss of sense of smell, and individual consideration for oral steroids, steroid rinses, and omega 3 supplements.

CLINICAL OTOLARYNGOLOGY (2021)

Article Otorhinolaryngology

Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell

Luca D'Ascanio et al.

Summary: This study found that olfactory dysfunction is more common in COVID-19 patients compared to healthy controls, with outpatients paradoxically reporting loss of smell more commonly than inpatients. Most patients with olfactory dysfunction recovered within 30 days, indicating a favorable prognosis.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

Article Biochemistry & Molecular Biology

Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters

Shinji Urata et al.

Summary: Olfactory dysfunction is a common symptom of COVID-19, but the damage and repair of the neuroepithelium after SARS-CoV-2 infection is still incomplete. In a study using golden Syrian hamsters, severe damage was observed in the olfactory epithelium post-inoculation, with the nasal septal region showing faster recovery. This suggests that anosmia related to SARS-CoV-2 infection may be fully reversible.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Otorhinolaryngology

Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial

Abdelrahman Ahmed Abdelalim et al.

Summary: The study found that using mometasone furoate nasal spray as a topical corticosteroid for post COVID-19 anosmia did not offer significant benefits over olfactory training, with no statistical differences in treatment outcomes and recovery rates.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Article Otorhinolaryngology

Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study

Rasheed Ali Rashid et al.

Summary: A clinical trial evaluating the therapeutic effect of nasal betamethasone drops in COVID-19-associated anosmia showed no significant impact on the recovery time compared to placebo. Age, smoking status, duration of anosmia, and co-presentation of ageusia with anosmia are important determinants for the recovery time of anosmia. Additional clinical trials taking these covariates into account are necessary.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Article Immunology

Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial

Hossein Kasiri et al.

Summary: The study aimed to evaluate the usage of mometasone furoate nasal spray in patients with severe microsmia or anosmia induced by COVID-19. The combination of mometasone furoate nasal spray with olfactory training showed greater improvement in patients with severe chronic anosmia by COVID-19 compared to olfactory training alone.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Microbiology

Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study

Sven Saussez et al.

Summary: The early use of oral corticosteroids or nasal corticosteroids in combination with olfactory training seems to have better efficacy in improving COVID-19 related olfactory dysfunction compared to olfactory training alone, but the long-term outcomes remain uncertain, requiring further research to validate.

PATHOGENS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Waradon Sungnak et al.

NATURE MEDICINE (2020)

Article Otorhinolaryngology

Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Review Otorhinolaryngology

COVID-19 and anosmia: A review based on up-to-date knowledge

Xiangming Meng et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2020)

Article Pharmacology & Pharmacy

Virology, pathogenesis, diagnosis and in-line treatment of COVID-19

Pavan Kumar Samudrala et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Article Otorhinolaryngology

Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Article Multidisciplinary Sciences

Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses In Vitro

Janet M. Davies et al.

PLOS ONE (2011)

Article Medicine, General & Internal

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Social Sciences, Mathematical Methods

A re-evaluation of random-effects meta-analysis

Julian P. T. Higgins et al.

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)

Article Otorhinolaryngology

Local and systemic administration of corticosteroids in the treatment of olfactory loss

S Heilmann et al.

AMERICAN JOURNAL OF RHINOLOGY (2004)

Article Public, Environmental & Occupational Health

Estimating the relative risk in cohort studies and clinical trials of common outcomes

LA McNutt et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)